The Chemours Company (CC) Bundle
Who Invests in The Chemours Company (CC) and Why?
Investor Profile Analysis for Chemical Manufacturing Company
Investor composition as of Q4 2023 reveals a complex investment landscape:
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 87.6% | 124.3 million |
| Retail Investors | 12.4% | 17.6 million |
Key Institutional Investors
- Vanguard Group: 15.3% ownership
- BlackRock Inc: 12.7% ownership
- State Street Corporation: 8.9% ownership
Investment Motivations
Investor attraction driven by:
- Price-to-Earnings Ratio: 11.2
- Dividend Yield: 3.6%
- Market Capitalization: $6.3 billion
Investment Strategy Breakdown
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68% |
| Value Investing | 22% |
| Short-term Trading | 10% |
Institutional Ownership and Major Shareholders of The Chemours Company (CC)
Investor Profile Analysis for Chemical Manufacturing Company
Investor composition as of Q4 2023 reveals a complex investment landscape:
| Investor Type | Percentage Ownership | Total Shares |
|---|---|---|
| Institutional Investors | 87.6% | 124.3 million |
| Retail Investors | 12.4% | 17.6 million |
Key Institutional Investors
- Vanguard Group: 15.3% ownership
- BlackRock Inc: 12.7% ownership
- State Street Corporation: 8.9% ownership
Investment Motivations
Investor attraction driven by:
- Price-to-Earnings Ratio: 11.2
- Dividend Yield: 3.6%
- Market Capitalization: $6.3 billion
Investment Strategy Breakdown
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68% |
| Value Investing | 22% |
| Short-term Trading | 10% |
Key Investors and Their Influence on The Chemours Company (CC)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, the institutional ownership for the company stands at 88.47%, representing significant institutional investor involvement.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| The Vanguard Group, Inc. | 36,782,518 | 15.2% |
| BlackRock Inc. | 29,456,712 | 12.1% |
| State Street Corporation | 22,341,987 | 9.3% |
Institutional Ownership Trends
- Net institutional purchases in last quarter: $124.6 million
- Number of institutional investors: 456
- Institutional ownership change: +2.3% from previous quarter
Significant Ownership Metrics
Insider ownership currently represents 2.6% of total shares, with key executives holding substantial stakes.
| Investor Type | Total Shares | Percentage |
|---|---|---|
| Mutual Funds | 82,456,123 | 34.2% |
| Hedge Funds | 41,223,456 | 17.1% |
| Pension Funds | 33,789,012 | 14.0% |
Market Impact and Investor Sentiment of The Chemours Company (CC)
Key Investors and Their Impact
As of Q4 2023, The Chemours Company (CC) has significant institutional investor presence with 85.4% institutional ownership.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 44,237,570 | 16.74% |
| BlackRock Inc | 37,221,983 | 14.10% |
| State Street Corporation | 22,445,717 | 8.50% |
Recent Investor Movements
- Vanguard Group increased holdings by 2.3% in last reporting period
- BlackRock reduced position by 1.7% in recent quarter
- Dimensional Fund Advisors LP holds 7.42% of outstanding shares
Investor ownership breakdown reveals concentrated institutional investment with top 10 investors controlling 52.6% of total shares.
The Chemours Company (CC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.